Combination Therapy and Nanoparticulate Systems: Smart Approaches for the Effective Treatment of Breast Cancer
Breast cancer has become one of the biggest concerns for oncologists in the past few decades because of its unpredictable etiopathology and nonavailability of personalized translational medicine. The number of women getting affected by breast cancer has increased dramatically, owing to lifestyle and...
Main Authors: | Shivaprasad Gadag, Shristi Sinha, Yogendra Nayak, Sanjay Garg, Usha Y. Nayak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/6/524 |
Similar Items
-
Current and New Novel Combination Treatments for Metastatic Triple-Negative Breast Cancer
by: Mehrnoosh Pauls, et al.
Published: (2022-07-01) -
Targeting the PI3K/AKT/mTOR pathway in lung cancer: mechanisms and therapeutic targeting
by: Min Qiang, et al.
Published: (2025-02-01) -
Autophagy as a Vital Therapy Target for Renal Cell Carcinoma
by: Ying-hua He, et al.
Published: (2021-02-01) -
Expert consensus on the clinical application of PI3K/AKT/mTOR inhibitors in the treatment of advanced breast cancer
by: The Society of Clinical Research of Oncology Medications of China Anticancer Association, et al.
Published: (2022-06-01) -
Targeting PI3K/Akt/mTOR Signaling In Cancer
by: Camillo ePorta, et al.
Published: (2014-04-01)